KARADAĞ, Ö. Et Al. 2016. Viral hepatitis screening guideline before biological drug use in rheumatic patients. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.3, no.1 , 25-28.

KARADAĞ, Ö., KAŞİFOĞLU, T., Ozer, B., Kaymakoglu, S., Kus, Y., İNANÇ, M., ... KESER, G.(2016). Viral hepatitis screening guideline before biological drug use in rheumatic patients. EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.3, no.1, 25-28.

KARADAĞ, ÖMER Et Al. "Viral hepatitis screening guideline before biological drug use in rheumatic patients," EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.3, no.1, 25-28, 2016

KARADAĞ, ÖMER Et Al. "Viral hepatitis screening guideline before biological drug use in rheumatic patients." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.3, no.1, pp.25-28, 2016

KARADAĞ, Ö. Et Al. (2016) . "Viral hepatitis screening guideline before biological drug use in rheumatic patients." EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.3, no.1, pp.25-28.

@article{article, author={ÖMER KARADAĞ Et Al. }, title={Viral hepatitis screening guideline before biological drug use in rheumatic patients}, journal={EUROPEAN JOURNAL OF RHEUMATOLOGY}, year=2016, pages={25-28} }